Suppr超能文献

组织学亚型是否影响乳头状肾细胞癌患者的肿瘤学结局:一项系统评价和荟萃分析的证据

Whether histologic subtyping affect the oncological outcomes of patients with papillary renal cell carcinoma: evidence from a systematic review and meta-analysis.

作者信息

Xiong Shengwei, Zhu Weijie, Li Xinfei, Yu Yanfei, Yang Kunlin, Zhang Lei, Mi Yue, Li Xuesong, Zhou Liqun

机构信息

Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Centre, Beijing, China.

出版信息

Transl Androl Urol. 2021 Aug;10(8):3255-3266. doi: 10.21037/tau-21-329.

Abstract

BACKGROUND

Whether the histologic subtype (type 1 and type 2) of papillary renal cell carcinoma (pRCC) is a tool to predict the prognosis is of great debate. This study is aimed to evaluate the prognostic significance of histologic subtype in patients with pRCC after surgery through a systematic review and meta-analysis.

METHODS

We searched PubMed, the Web of Science, Cochrane library and EMBASE databases to identify studies published until January 20, 2021 according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Studies were deemed eligible if they compared the overall survival (OS), cancer specific survival (CSS), recurrence-free survival (RFS) or disease-free survival (DFS) between patients with type 1 or type 2 pRCC. And the corresponding hazard ratios (HRs) and 95% conference intervals (CIs) were collected for meta-analysis and further subgroup analysis.

RESULTS

Overall 22 studies with a total of 4,494 patients were considered eligible and included for the systematic review and meta-analysis. The pooled results showed that type 2 pRCC was associated with a worse OS (pooled HR 1.61, 95% CI: 1.10-2.36, P=0.02) and CSS (pooled HR 1.59, 95% CI: 1.00-2.51, P=0.05). However, the subgroup analysis yielded the same result as the initial analysis only when the HRs were extracted from univariate analysis. In studies with multivariate analysis, type 2 pRCC was not statistically associated with a worse OS (pooled HR 1.22, 95% CI: 0.97-1.53, P=0.27), CSS (pooled HR 1.16, 95% CI: 0.67-2.00, P=0.60), and DFS (pooled HR 1.33, 95% CI: 0.93-1.91, P=0.12) compared to type 1 pRCC.

DISCUSSION

Histologic subtype is not an independent prognostic factor for patients with pRCC, although the result needs to be taken with caution. And studies with retrospective study design, larger sample size and longer follow-up period are required to verify these results.

摘要

背景

肾乳头状细胞癌(pRCC)的组织学亚型(1型和2型)是否可作为预测预后的工具存在很大争议。本研究旨在通过系统评价和荟萃分析评估pRCC患者术后组织学亚型的预后意义。

方法

我们检索了PubMed、科学网、Cochrane图书馆和EMBASE数据库,以识别根据PRISMA(系统评价和荟萃分析的首选报告项目)指南截至2021年1月20日发表的研究。如果研究比较了1型或2型pRCC患者之间的总生存期(OS)、癌症特异性生存期(CSS)、无复发生存期(RFS)或无病生存期(DFS),则认为该研究符合纳入标准。收集相应的风险比(HRs)和95%置信区间(CIs)进行荟萃分析和进一步的亚组分析。

结果

共有22项研究,总计4494例患者被认为符合纳入标准并纳入系统评价和荟萃分析。汇总结果显示,2型pRCC与较差的OS(汇总HR 1.61,95%CI:1.10-2.36,P=0.02)和CSS(汇总HR 1.59,95%CI:1.00-2.51,P=0.05)相关。然而,仅当从单变量分析中提取HRs时,亚组分析得出的结果与初始分析相同。在多变量分析的研究中,与1型pRCC相比,2型pRCC在OS(汇总HR 1.22,95%CI:0.97-1.53,P=0.27)、CSS(汇总HR 1.16,95%CI:0.67-2.00,P=0.60)和DFS(汇总HR 1.33,95%CI:0.93-1.91,P=0.12)方面无统计学差异。

讨论

组织学亚型不是pRCC患者的独立预后因素,尽管该结果需谨慎对待。需要采用回顾性研究设计、更大样本量和更长随访期的研究来验证这些结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验